Related Experiment Videos
Clinical and molecular study of DiGeorge sequence
A Levy-Mozziconacci1, F Wernert, P Scambler
1Department of Paediatrics and Medical Genetics, Hôpital d'Enfants de la Timone, Marseilles, France.
European Journal of Pediatrics
|November 1, 1994
Summary
DiGeorge sequence (DGS) is a developmental disorder caused by chromosome 22q11 deletion. Molecular analysis confirmed this deletion in all 16 patients studied, highlighting the importance of genetic testing for diagnosis.
Area of Science:
- Genetics
- Developmental Biology
- Pediatrics
Background:
- DiGeorge sequence (DGS) is a complex developmental disorder affecting pharyngeal pouch derivatives.
- Key features include thymus/parathyroid issues, conotruncal heart defects, and facial dysmorphism.
- Most DGS cases are linked to 22q11.2 haploinsufficiency.
Purpose of the Study:
- To investigate the genetic basis of DGS in a cohort of patients.
- To evaluate the utility of molecular diagnostic techniques in DGS.
- To discuss the implications of genetic findings for diagnosis, prognosis, and counseling.
Main Methods:
- Clinical assessment based on established criteria (heart defect, hypocalcemia, thymus, facial features).
- Molecular analysis using fluorescent in situ hybridization (FISH) and DNA dosage analysis.
- Study included 16 patients with DGS, including one familial case.
Main Results:
- A deletion in the 22q11 region was identified in all 16 patients.
- Molecular analysis confirmed the genetic cause in every case.
- Clinical diagnosis remains crucial alongside molecular findings.
Conclusions:
- Molecular techniques are essential for confirming DGS diagnosis.
- Genetic confirmation impacts prognosis and genetic counseling for families.
- Integrated clinical and molecular approaches optimize DGS management.